130 related articles for article (PubMed ID: 3952377)
1. Intrathoracic amyloid lymphadenopathy.
Naschitz JE; Yeshurun D; Pick AI
Respiration; 1986; 49(1):73-6. PubMed ID: 3952377
[TBL] [Abstract][Full Text] [Related]
2. [Localizing amyloidosis--lymph node].
Honda T; Kobayashi T
Nihon Rinsho; 1991 Apr; 49(4):923-6. PubMed ID: 2072555
[No Abstract] [Full Text] [Related]
3. AL amyloidosis manifesting as systemic lymphadenopathy.
Matsuda M; Gono T; Shimojima Y; Yoshida T; Katoh N; Hoshii Y; Yamada T; Ikeda S
Amyloid; 2008 Jun; 15(2):117-24. PubMed ID: 18484338
[TBL] [Abstract][Full Text] [Related]
4. Toxic intrathoracic goiter and mediastinal lymphadenopathy: an unusual presentation of systemic primary AL amyloidosis.
de Saedeleer B; Poppe K; Lacor P; de Mey J; Vincken W; Bourgain C; Velkeniers B
Acta Clin Belg; 2003; 58(1):46-9. PubMed ID: 12723261
[TBL] [Abstract][Full Text] [Related]
5. Primary amyloidosis presenting with predominant lymphnodal masses.
Kumar D; Singh AC; Neehar P; Usha ; Tandon R; Tripathi K
J Assoc Physicians India; 2005 Apr; 53():312-3. PubMed ID: 15987018
[TBL] [Abstract][Full Text] [Related]
6. Amyloid tumour of the breast simulating carcinoma.
Goonatillake HD; Allsop JR
Aust N Z J Surg; 1988 Jul; 58(7):589-90. PubMed ID: 3254147
[TBL] [Abstract][Full Text] [Related]
7. Lymphadenopathy as a manifestation of amyloidosis: a case series.
Fu J; Seldin DC; Berk JL; Sun F; O'Hara C; Cui H; Sanchorawala V
Amyloid; 2014 Dec; 21(4):256-60. PubMed ID: 25208081
[TBL] [Abstract][Full Text] [Related]
8. Hemorrhagic lymphadenopathy as a presenting feature of primary al amyloidosis.
Hanley JP; MacLean FR; Evans JL; Colls BM; Robinson BA; Patton WN; Heaton DC
Pathology; 2000 Feb; 32(1):21-3. PubMed ID: 10740800
[TBL] [Abstract][Full Text] [Related]
9. Amyloidosis presenting in the head and neck: a report of two cases.
Thorbury L; Ryan K; Martin L; Hunter K; Hegarty AM
Br J Hosp Med (Lond); 2015 Oct; 76(10):600-1. PubMed ID: 26457943
[No Abstract] [Full Text] [Related]
10. Pulmonary amyloidoma and hilar adenopathy. Rare manifestations of primary amyloidosis.
Desai RA; Mahajan VK; Benjamin S; Van Ordstrand HS; Cordasco EM
Chest; 1979 Aug; 76(2):170-3. PubMed ID: 456056
[TBL] [Abstract][Full Text] [Related]
11. Primary amyloidosis presenting with massive generalized lymphadenopathy.
Kutlay S; Hasan T; Keven K; Nergizoglu G; Ates K; Karatan O
Leuk Lymphoma; 2002 Jul; 43(7):1501-3. PubMed ID: 12389637
[TBL] [Abstract][Full Text] [Related]
12. Proteinaceous lymphadenopathy in a patient with known rheumatoid arthritis--case report and review of the literature.
al Rikabi AC; Naddaf HO; al Balla SR; al Sohaibani MO
Br J Rheumatol; 1995 Nov; 34(11):1087-9. PubMed ID: 8542213
[TBL] [Abstract][Full Text] [Related]
13. Surgical removal of amyloid-laden lymph nodes: a possible therapeutic approach in a primary systemic AL amyloidosis patient with focal lymphadenopathy.
Matsuda M; Katoh N; Tazawa K; Shimojima Y; Mishima Y; Sano K; Ikeda S
Amyloid; 2011 Jun; 18(2):79-82. PubMed ID: 21401322
[TBL] [Abstract][Full Text] [Related]
14. Lymph node enlargement due to amyloid.
Newland JR; Linke RP; Kleinsasser O; Lennert K
Virchows Arch A Pathol Anat Histopathol; 1983; 399(2):233-6. PubMed ID: 6404052
[TBL] [Abstract][Full Text] [Related]
15. Proteinaceous lymphadenopathy with hypergammaglobulinemia.
Osborne BM; Butler JJ; Mackay B
Am J Surg Pathol; 1979 Apr; 3(2):137-45. PubMed ID: 532845
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin-related amyloidosis presenting as recurrent isolated lymph node involvement.
Kahn H; Strauchen JA; Gilbert HS; Fuchs A
Arch Pathol Lab Med; 1991 Sep; 115(9):948-50. PubMed ID: 1929793
[TBL] [Abstract][Full Text] [Related]
17. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
Tazawa K; Katoh N; Shimojima Y; Matsuda M; Ikeda S
Amyloid; 2009; 16(3):183-5. PubMed ID: 19590992
[TBL] [Abstract][Full Text] [Related]
18. Thoracic lymphadenopathy in benign diseases: A state of the art review.
Nin CS; de Souza VV; do Amaral RH; Schuhmacher Neto R; Alves GR; Marchiori E; Irion KL; Balbinot F; Meirelles GS; Santana P; Gomes AC; Hochhegger B
Respir Med; 2016 Mar; 112():10-7. PubMed ID: 26860219
[TBL] [Abstract][Full Text] [Related]
19. [DIAGNOSTIC SIGNIFICANCE OF CYTOLOGICAL AND HISTOLOGICAL INVESTIGATION OF THE BIOPSY MATERIAL FOR DETERMINATION OF ETIOLOGY OF THE INTRATHORACIC LYMPHADENOPATHY SYNDROME].
Zagaba LM; Opanasenko MS; Borysova VI; Yatsyna MF; Tereshkovych OV; Kshanovskiy OE; Kupchak IM; Konik BM; Kalenychenko MI; Obremska OK; Bychkovskiy VB
Klin Khir; 2016 Feb; (2):56-9. PubMed ID: 27244922
[TBL] [Abstract][Full Text] [Related]
20. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
Tazawa K; Katoh N; Shimojima Y; Matsuda M; Ikeda S
Amyloid; 2009 Dec; 16(4):243-5. PubMed ID: 19922338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
